Log In
BCIQ
Print this Print this
 

4WF

  Manage Alerts
Collapse Summary General Information
Company Esperion Therapeutics Inc.
DescriptionNext-generation injectable, synthetic apolipoprotein A-1 (APOA1) therapy
Molecular Target Apolipoprotein A-1 (APOA1)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today